Is Kratom (Whole Leaf / Mitragynine) Legal in District of Columbia? (2026)

Rule type

permanent

Tier

unscheduled

Effectively prohibitive

DC regulatory 7-OH listing has no concentration threshold; all leaf carries trace 7-OH (but listing is conflicted/rarely enforced)

Controlling language, verbatim

D.C. Code Sec. 48-902.04 Schedule I does not list mitragynine, 7-hydroxymitragynine, mitragynine pseudoindoxyl, or speciociliatine; no analogue catch-all reaches them; DC has no Kratom Consumer Protection Act.

Source of excerpt

Citations

1. 22-B DCMR 1201 Schedule I Enumerated (Department of Health), as amended effective 12/2/2016 - proof of absence for mitragynine / Mitragyna, 1201.1(h)(16) (DC Office of Documents and Administrative Issuances (DCRegs), 2026-09-22) PRIMARYOFFICIAL

Change history

• 2026-09-22Headline updated: "Not listed in DC Schedule I: neither D.C. Code 48-902.04 nor 22-B DCMR 1201 names mitragynine or Mitragyna speciosa (the 2016 DC rule scheduled 7-hydroxymitragynine only)".

Where Kratom (Whole Leaf / Mitragynine) stands across the country

Among District of Columbia's 2 neighbors, Maryland and Virginia are restricted.

Open the interactive map · Every compound in District of Columbia

Federal posture

Not federally scheduled. Kratom leaf / mitragynine not federally scheduled; DEA 7-OH re-notice (Nov 13+) reaches extracts under 100:1 mitragynine to 7-OH Federal detail

Pending deadlines

• 2026-11-13 · Federal · DEA 7-OH threshold order would reach kratom extracts under 100:1 mitragynine to 7-OH (DEA-1570 / FR 2026-20943)
  On or after Nov 13, 2026: kratom products whose mitragynine is less than 100 times their 7-OH (or 7-OH plus pseudoindoxyl), or above 1 mg/g or 1 mg/mL of those, would be Schedule I. Plain leaf and typical extracts sit above 100:1; enhanced 7-OH kratom does not. Kratom leaf and mitragynine are not scheduled.

Verbatim law on file for District of Columbia

1 instrument on file for this compound's framework in District of Columbia; 1 of 1 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.

D.C. Official Code Sec. 48-902.04 (Schedule I enumerated). Opiate class (1) is a closed NAMED list ("any of the following opiates, including their isomers, esters, ethers, salts...") that does NOT include mitragynine, 7-hydroxymitragynine, mitragynine pseudoindoxyl, or speciociliatine. Hallucinogen class (3) ("any material...which contains any quantity of the following hallucinogenic substances, its salts, isomers and salts of isomers...") runs alphabetically ...Lysergic acid diethylamide; Methoxetamine; Mescaline; Peyote... with NO "Mitragynine" entry at the M slot. DC Schedule I has NO general controlled-substance-analogue catch-all (only Synthetic Cathinones = 2-amino-1-propanone structures, and Synthetic Cannabimimetic Agents = cannabinoid-receptor agonists, neither of which reaches indole alkaloids). A full-text search of Sec. 48-902.04 for mitragynine / kratom / 7-hydroxy / pseudoindoxyl / speciociliatine returns ZERO matches. DC has enacted no Kratom Consumer Protection Act.

Related

Kratom (Whole Leaf / Mitragynine) in neighboring states

• Kratom (Whole Leaf / Mitragynine) in Maryland Restricted
• Kratom (Whole Leaf / Mitragynine) in Virginia Restricted

Kratom (Whole Leaf / Mitragynine) in other states

Same framework in District of Columbia

• Mitragynine Pseudoindoxyl in District of Columbia Illegal
• 7-OH (7-Hydroxymitragynine) in District of Columbia Illegal
• Speciociliatine in District of Columbia Legal

Other compounds in District of Columbia

Cite this page